• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管中国特大城市上海的污水处理率很高,但心血管和降脂药物的残留对水生生态系统构成了威胁。

Residues of Cardiovascular and Lipid-Lowering Drugs Pose a Risk to the Aquatic Ecosystem despite a High Wastewater Treatment Ratio in the Megacity Shanghai, China.

机构信息

State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, School of Environmental Science and Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.

State Environmental Protection Key Lab of Environmental Risk Assessment and Control on Chemical Processes, School of Resources & Environmental Engineering, East China University of Science and Technology, Shanghai 200237, China.

出版信息

Environ Sci Technol. 2022 Feb 15;56(4):2312-2322. doi: 10.1021/acs.est.1c05520. Epub 2022 Feb 7.

DOI:10.1021/acs.est.1c05520
PMID:35129343
Abstract

The residues of pharmaceuticals in surface waters of megacities and ecotoxicological implications are of particular concern. In this study, we combined field investigations and model simulations to explore the contamination of cardiovascular and lipid-lowering drugs, one group of the most prescribed medications globally, in surface waters of a typical megacity, Shanghai, with a high wastewater treatment ratio (≈96%). Among 26 target substances, 19 drugs were detected with aqueous concentrations ranging from 0.2 (ketanserin) to 715 ng/L (telmisartan). Of them, angiotensin II receptor antagonists, telmisartan and irbesartan, were dominant besides β-blockers. Spatial distribution analysis demonstrated their much higher levels in tributaries compared to the mainstream. The results of model simulations and field investigation revealed relatively low concentrations of cardiovascular and lipid-lowering drugs in surface waters of Shanghai compared to other cities in highly developed countries, which is associated with low per capita usage in China. Ecotoxicological studies in zebrafish embryos further revealed developmental effects, including altered hatching success and heart rate, by irbesartan, telmisartan, lidocaine, and their mixtures at ng/L concentrations, which are typical levels in surface waters. Overall, the present results suggest that the high wastewater treatment ratio was not sufficient to protect fish species in the aquatic ecosystem of Shanghai. Exposure to cardiovascular and lipid-lowering drugs and associated risks will further increase in the future due to healthcare improvements and population aging.

摘要

在特大城市的地表水中,药物残留及其生态毒理学影响尤其值得关注。本研究结合野外调查和模型模拟,探讨了心血管和降血脂药物(一类全球范围内使用最广泛的处方药物)在污水处理率较高(约 96%)的特大城市——上海的地表水中的污染情况。在所检测的 26 种目标物质中,有 19 种药物被检出,其在水中的浓度范围为 0.2(酮色林)至 715ng/L(替米沙坦)。其中,血管紧张素 II 受体拮抗剂替米沙坦和厄贝沙坦,以及β受体阻滞剂,是除β受体阻滞剂之外的主要药物。空间分布分析表明,它们在支流中的浓度明显高于主流。模型模拟和野外调查的结果表明,与高度发达的国家的其他城市相比,上海地表水中的心血管和降血脂药物浓度相对较低,这与中国的人均用量较低有关。在斑马鱼胚胎中的生态毒理学研究进一步表明,替米沙坦、厄贝沙坦、利多卡因及其混合物在纳克/升浓度下,会对胚胎孵化成功率和心率产生发育影响,这一浓度在地表水中较为典型。总的来说,本研究结果表明,高污水处理率不足以保护上海水生态系统中的鱼类物种。随着医疗保健的改善和人口老龄化,未来接触心血管和降血脂药物及其相关风险将进一步增加。

相似文献

1
Residues of Cardiovascular and Lipid-Lowering Drugs Pose a Risk to the Aquatic Ecosystem despite a High Wastewater Treatment Ratio in the Megacity Shanghai, China.尽管中国特大城市上海的污水处理率很高,但心血管和降脂药物的残留对水生生态系统构成了威胁。
Environ Sci Technol. 2022 Feb 15;56(4):2312-2322. doi: 10.1021/acs.est.1c05520. Epub 2022 Feb 7.
2
Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.关注中的新兴污染物在大湖流域:环境暴露分析。
Rev Environ Contam Toxicol. 2010;207:1-93. doi: 10.1007/978-1-4419-6406-9_1.
3
Cardiovascular drugs and lipid regulating agents in surface waters at global scale: Occurrence, ecotoxicity and risk assessment.全球地表水心血管药物和调脂药物:检出情况、生态毒性及风险评估。
Sci Total Environ. 2020 Aug 10;729:138770. doi: 10.1016/j.scitotenv.2020.138770. Epub 2020 Apr 24.
4
Occurrence and health risk assessment of pharmaceutical and personal care products (PPCPs) in tap water of Shanghai.上海自来水中药品和个人护理产品(PPCPs)的出现及健康风险评估。
Ecotoxicol Environ Saf. 2019 Nov 15;183:109497. doi: 10.1016/j.ecoenv.2019.109497. Epub 2019 Aug 7.
5
Risks to aquatic environments posed by 14 pharmaceuticals as illustrated by their effects on zebrafish behaviour.14 种药物对斑马鱼行为的影响表明它们对水生环境的危害。
Sci Total Environ. 2021 Jun 1;771:145450. doi: 10.1016/j.scitotenv.2021.145450. Epub 2021 Jan 28.
6
Pharmaceuticals in two watersheds in Eastern China and their ecological risks.中国东部两个流域中的药物及其生态风险。
Environ Pollut. 2021 May 15;277:116773. doi: 10.1016/j.envpol.2021.116773. Epub 2021 Feb 19.
7
Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda.维多利亚湖(乌干达)水体中选定药物化合物的出现、分布情况及生态毒理学风险评估。
Chemosphere. 2020 Jan;239:124642. doi: 10.1016/j.chemosphere.2019.124642. Epub 2019 Aug 26.
8
Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.地表水和地下水中污染物的来源、途径及相对风险:为沃克顿调查准备的一份报告
J Toxicol Environ Health A. 2002 Jan 11;65(1):1-142. doi: 10.1080/152873902753338572.
9
Environmental risk assessment and bioaccumulation of pharmaceuticals in a large urbanized estuary.环境风险评估与都市化河口区中药物的生物积累
Sci Total Environ. 2021 Aug 20;783:147021. doi: 10.1016/j.scitotenv.2021.147021. Epub 2021 Apr 19.
10
Pharmaceuticals and personal care products in the aquatic environment in China: a review.中国水生态环境中的药品和个人护理产品:综述。
J Hazard Mater. 2013 Nov 15;262:189-211. doi: 10.1016/j.jhazmat.2013.08.040. Epub 2013 Aug 28.

引用本文的文献

1
Pharmaceuticals in raw and treated water from drinking water treatment plants nationwide: Insights into their sources and exposure risk assessment.全国饮用水处理厂原水和处理水中的药物:对其来源和暴露风险评估的见解。
Water Res X. 2024 Sep 3;24:100256. doi: 10.1016/j.wroa.2024.100256. eCollection 2024 Sep 1.
2
Environmental impact of cardiovascular healthcare.心血管医疗保健的环境影响。
Open Heart. 2023 May;10(1). doi: 10.1136/openhrt-2023-002279.